This is a Validated Antibody Database (VAD) review about human PUMA, based on 47 published articles (read how Labome selects the articles), using PUMA antibody in all methods. It is aimed to help Labome visitors find the most suited PUMA antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
PUMA synonym: JFY-1; JFY1; PUMA

Knockout validation
Abcam
domestic rabbit polyclonal
  • western blot knockout validation; mouse; loading ...; fig 4a
  • immunohistochemistry; mouse; loading ...; fig 3a
  • immunohistochemistry; human; loading ...; fig 3c
Abcam PUMA antibody (Abcam, ab9643) was used in western blot knockout validation on mouse samples (fig 4a), in immunohistochemistry on mouse samples (fig 3a) and in immunohistochemistry on human samples (fig 3c). Cell Death Dis (2021) ncbi
Santa Cruz Biotechnology
mouse monoclonal (G-3)
  • western blot; human; 1:500; loading ...; fig 8f
Santa Cruz Biotechnology PUMA antibody (Santa Cruz, sc-374223) was used in western blot on human samples at 1:500 (fig 8f). NPJ Breast Cancer (2021) ncbi
mouse monoclonal (B-6)
  • western blot; human; 1:50; loading ...; fig 2d
Santa Cruz Biotechnology PUMA antibody (Santa Cruz Biotechnology, sc-377015) was used in western blot on human samples at 1:50 (fig 2d). Cancers (Basel) (2021) ncbi
mouse monoclonal (G-3)
  • western blot; rat; 1:100; loading ...; fig 6f
Santa Cruz Biotechnology PUMA antibody (Santa Cruz Biotechnology, sc-374223) was used in western blot on rat samples at 1:100 (fig 6f). Cell Prolif (2021) ncbi
mouse monoclonal (G-3)
  • western blot; human; loading ...; fig 4b
Santa Cruz Biotechnology PUMA antibody (Santa Cruz Biotechnology, G-3) was used in western blot on human samples (fig 4b). Cell Death Dis (2019) ncbi
mouse monoclonal (G-3)
  • western blot; mouse; 1:500; loading ...; fig 5d
Santa Cruz Biotechnology PUMA antibody (Santa Cruz Biotechnology Inc, sc-374223) was used in western blot on mouse samples at 1:500 (fig 5d). elife (2018) ncbi
mouse monoclonal (G-3)
  • western blot; human; fig 4
Santa Cruz Biotechnology PUMA antibody (Santa Cruz, sc-374223) was used in western blot on human samples (fig 4). Oncotarget (2016) ncbi
mouse monoclonal (B-6)
  • western blot; mouse; fig 7
Santa Cruz Biotechnology PUMA antibody (anta Cruz Biotechnology, SC-377015) was used in western blot on mouse samples (fig 7). Nat Commun (2016) ncbi
mouse monoclonal (G-3)
  • immunocytochemistry; human; fig 2C
  • western blot; human; fig 2A
Santa Cruz Biotechnology PUMA antibody (Santa Cruz, sc-374223) was used in immunocytochemistry on human samples (fig 2C) and in western blot on human samples (fig 2A). Sci Rep (2015) ncbi
mouse monoclonal (G-3)
  • western blot; human; fig 6
Santa Cruz Biotechnology PUMA antibody (Santa Cruz, sc-374223) was used in western blot on human samples (fig 6). Oncotarget (2015) ncbi
mouse monoclonal (G-3)
  • western blot; human; fig 2
Santa Cruz Biotechnology PUMA antibody (Santa Cruz, sc-374223) was used in western blot on human samples (fig 2). Cell Death Differ (2015) ncbi
mouse monoclonal (B-6)
  • western blot; human; 1:1000
In order to study the effect of caffeic acid phenethyl ester on CD133+ melanoma, Santa Cruz Biotechnology PUMA antibody (Santa Cruz, sc-377015) was used in western blot on human samples at 1:1000. Cancer Lett (2015) ncbi
mouse monoclonal (B-6)
  • western blot; mouse; 1:1000; fig 6
In order to investigate whether drugs that increase Hsp70/Hsp110 levels protect cells from traumatic brain injury, Santa Cruz Biotechnology PUMA antibody (Santa Cruz, sc-377015) was used in western blot on mouse samples at 1:1000 (fig 6). J Neurochem (2014) ncbi
mouse monoclonal (G-3)
  • immunoprecipitation; human
  • western blot; human
Santa Cruz Biotechnology PUMA antibody (Santa Cruz Biotechnology, sc-374223) was used in immunoprecipitation on human samples and in western blot on human samples . PLoS ONE (2014) ncbi
Abcam
domestic rabbit polyclonal
  • western blot knockout validation; mouse; loading ...; fig 4a
  • immunohistochemistry; mouse; loading ...; fig 3a
  • immunohistochemistry; human; loading ...; fig 3c
Abcam PUMA antibody (Abcam, ab9643) was used in western blot knockout validation on mouse samples (fig 4a), in immunohistochemistry on mouse samples (fig 3a) and in immunohistochemistry on human samples (fig 3c). Cell Death Dis (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 4a
Abcam PUMA antibody (Abcam, ab9643) was used in western blot on human samples (fig 4a). elife (2019) ncbi
Novus Biologicals
domestic rabbit polyclonal (OTI1D2)
  • western blot; mouse; loading ...; fig 3a
Novus Biologicals PUMA antibody (Novus, NBP1-76639) was used in western blot on mouse samples (fig 3a). Oxid Med Cell Longev (2019) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (D30C10)
  • western blot; human; 1:500; loading ...; fig 7f
Cell Signaling Technology PUMA antibody (Cell Signaling Technology, 12450) was used in western blot on human samples at 1:500 (fig 7f). elife (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 5a
Cell Signaling Technology PUMA antibody (Cell Signaling, 4976) was used in western blot on human samples at 1:1000 (fig 5a). Nat Commun (2020) ncbi
domestic rabbit monoclonal (D30C10)
  • western blot; human; loading ...; fig 6d
Cell Signaling Technology PUMA antibody (CST, 12450) was used in western blot on human samples (fig 6d). Sci Adv (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 5a
Cell Signaling Technology PUMA antibody (Cell Signaling Technology, 4976) was used in western blot on human samples (fig 5a). Nat Commun (2020) ncbi
domestic rabbit monoclonal (D30C10)
  • western blot; human; 1:250; loading ...; fig 5b
Cell Signaling Technology PUMA antibody (Cell Signaling Technology, 12450) was used in western blot on human samples at 1:250 (fig 5b). Anal Cell Pathol (Amst) (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 2a
Cell Signaling Technology PUMA antibody (Cell Signaling, 4976) was used in western blot on human samples at 1:1000 (fig 2a). Int J Oncol (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig s2c
Cell Signaling Technology PUMA antibody (CST, 4976) was used in western blot on human samples (fig s2c). Nat Commun (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 3b
Cell Signaling Technology PUMA antibody (Cell Signaling Technology, 4976) was used in western blot on human samples (fig 3b). Oncoimmunology (2018) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 3a
Cell Signaling Technology PUMA antibody (Cell Signaling, 4976) was used in western blot on human samples (fig 3a). Oncotarget (2017) ncbi
domestic rabbit monoclonal (D30C10)
  • western blot; human; 1:1000; loading ...; fig s4a
Cell Signaling Technology PUMA antibody (Cell Signaling, 12450) was used in western blot on human samples at 1:1000 (fig s4a). Nat Med (2017) ncbi
domestic rabbit monoclonal (D30C10)
  • western blot; human; 1:1000; loading ...; fig 6b
Cell Signaling Technology PUMA antibody (Cell signaling, 12450) was used in western blot on human samples at 1:1000 (fig 6b). Biochem Pharmacol (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 1a
In order to observe that chronic presence of internalized Escherichia coli leads to enhanced oncogenicity in colon cancer cells, Cell Signaling Technology PUMA antibody (cell signalling, 4976) was used in western blot on human samples (fig 1a). Cell Death Dis (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 6a
Cell Signaling Technology PUMA antibody (CST, 4976) was used in western blot on human samples (fig 6a). Cell Death Dis (2017) ncbi
domestic rabbit monoclonal (D30C10)
  • western blot; human; loading ...; fig 2
In order to report the effects of NVP-CGM097 on the p53wildtype GOT1 cells, Cell Signaling Technology PUMA antibody (Cell Signaling, 12450) was used in western blot on human samples (fig 2). Neuroendocrinology (2018) ncbi
domestic rabbit monoclonal (D30C10)
  • western blot; human; loading ...; fig 1a
In order to elucidate the mechanism by which GRWD1 regulates p53 levels, Cell Signaling Technology PUMA antibody (Cell Signaling, 12450) was used in western blot on human samples (fig 1a). EMBO Rep (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 5f
Cell Signaling Technology PUMA antibody (Cell Signaling, 4976) was used in western blot on human samples (fig 5f). Cancer Res (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 5b,5c,6b,6c,6d
Cell Signaling Technology PUMA antibody (Cell Signaling, 4976) was used in western blot on human samples (fig 5b,5c,6b,6c,6d). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 4b, 4d
Cell Signaling Technology PUMA antibody (Cell Signaling, 4976) was used in western blot on human samples (fig 4b, 4d). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 1f
In order to study how methylation of p53 affects its interactions with other proteins such as PUMA and p300/CBP, Cell Signaling Technology PUMA antibody (Cell Signaling, 4976) was used in western blot on human samples (fig 1f). Oncogene (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:500; loading ...; fig s6d
Cell Signaling Technology PUMA antibody (Cell Signaling, 4976S) was used in western blot on human samples at 1:500 (fig s6d). Nat Cell Biol (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 2
Cell Signaling Technology PUMA antibody (Cell Signaling, 4976) was used in western blot on human samples (fig 2). Cancer Cell Int (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:2000; loading ...; fig s1a
  • western blot; mouse; 1:2000; fig s1a
Cell Signaling Technology PUMA antibody (Cell Signaling, 4976) was used in western blot on human samples at 1:2000 (fig s1a) and in western blot on mouse samples at 1:2000 (fig s1a). Cell Death Differ (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 1
Cell Signaling Technology PUMA antibody (Cell Signaling Tech, 4976) was used in western blot on human samples (fig 1). Oncotarget (2016) ncbi
domestic rabbit monoclonal (D30C10)
  • western blot; human; 1:1000; fig 1
In order to investigate the effect of Obatoclax in esophageal cancer cells, Cell Signaling Technology PUMA antibody (Cell Signaling Tech, 12450) was used in western blot on human samples at 1:1000 (fig 1). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 3e
Cell Signaling Technology PUMA antibody (cell signalling, 4976) was used in western blot on human samples (fig 3e). EMBO Rep (2016) ncbi
domestic rabbit monoclonal (D30C10)
  • western blot; human; fig 1
Cell Signaling Technology PUMA antibody (Cell Signalling, 12450) was used in western blot on human samples (fig 1). Cell Death Dis (2016) ncbi
domestic rabbit monoclonal (D30C10)
  • western blot; human; fig 5
Cell Signaling Technology PUMA antibody (Cell Signaling Tech, 12450) was used in western blot on human samples (fig 5). PLoS ONE (2015) ncbi
domestic rabbit monoclonal (D30C10)
  • western blot; human; fig s3
Cell Signaling Technology PUMA antibody (Cell Signaling, 12450) was used in western blot on human samples (fig s3). PLoS ONE (2015) ncbi
ProSci
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 6
ProSci PUMA antibody (ProSci, 3041) was used in western blot on human samples (fig 6). Oncotarget (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 3
ProSci PUMA antibody (Pro-Sci, 3041) was used in western blot on human samples (fig 3). Genes Dev (2016) ncbi
domestic rabbit polyclonal
  • western blot; rat; fig 2
  • western blot; mouse; fig 5
ProSci PUMA antibody (ProSci, 3041) was used in western blot on rat samples (fig 2) and in western blot on mouse samples (fig 5). Cell Death Differ (2016) ncbi
Articles Reviewed
  1. Gyamfi J, Yeo J, Kwon D, Min B, Cha Y, Koo J, et al. Interaction between CD36 and FABP4 modulates adipocyte-induced fatty acid import and metabolism in breast cancer. NPJ Breast Cancer. 2021;7:129 pubmed publisher
  2. Tan S, Liu X, Chen L, Wu X, Tao L, Pan X, et al. Fas/FasL mediates NF-κBp65/PUMA-modulated hepatocytes apoptosis via autophagy to drive liver fibrosis. Cell Death Dis. 2021;12:474 pubmed publisher
  3. Loureiro J, Raimundo L, Calheiros J, Carvalho C, Barcherini V, Lima N, et al. Targeting p53 for Melanoma Treatment: Counteracting Tumour Proliferation, Dissemination and Therapeutic Resistance. Cancers (Basel). 2021;13: pubmed publisher
  4. Li Z, Meng Y, Liu C, Liu H, Cao W, Tong C, et al. Kcnh2 mediates FAK/AKT-FOXO3A pathway to attenuate sepsis-induced cardiac dysfunction. Cell Prolif. 2021;54:e12962 pubmed publisher
  5. Arai S, Varkaris A, Nouri M, Chen S, Xie L, Balk S. MARCH5 mediates NOXA-dependent MCL1 degradation driven by kinase inhibitors and integrated stress response activation. elife. 2020;9: pubmed publisher
  6. Bajpai R, Sharma A, Achreja A, Edgar C, Wei C, Siddiqa A, et al. Electron transport chain activity is a predictor and target for venetoclax sensitivity in multiple myeloma. Nat Commun. 2020;11:1228 pubmed publisher
  7. Aldonza M, Ku J, Hong J, Kim D, Yu S, Lee M, et al. Prior acquired resistance to paclitaxel relays diverse EGFR-targeted therapy persistence mechanisms. Sci Adv. 2020;6:eaav7416 pubmed publisher
  8. Lohard S, Bourgeois N, Maillet L, Gautier F, Fétiveau A, Lasla H, et al. STING-dependent paracriny shapes apoptotic priming of breast tumors in response to anti-mitotic treatment. Nat Commun. 2020;11:259 pubmed publisher
  9. El Kott A, Shati A, Al Kahtani M, Alqahtani S. Acylated Ghrelin Renders Chemosensitive Ovarian Cancer Cells Resistant to Cisplatin Chemotherapy via Activation of the PI3K/Akt/mTOR Survival Pathway. Anal Cell Pathol (Amst). 2019;2019:9627810 pubmed publisher
  10. Kabir S, Cidado J, Andersen C, Dick C, Lin P, Mitros T, et al. The CUL5 ubiquitin ligase complex mediates resistance to CDK9 and MCL1 inhibitors in lung cancer cells. elife. 2019;8: pubmed publisher
  11. Donadoni M, Cicalese S, Sarkar D, Chang S, Sariyer I. Alcohol exposure alters pre-mRNA splicing of antiapoptotic Mcl-1L isoform and induces apoptosis in neural progenitors and immature neurons. Cell Death Dis. 2019;10:447 pubmed publisher
  12. Sul O, Rajasekaran M, Park H, Suh J, Choi H. MicroRNA-29b Enhances Osteoclast Survival by Targeting BCL-2-Modifying Factor after Lipopolysaccharide Stimulation. Oxid Med Cell Longev. 2019;2019:6018180 pubmed publisher
  13. Liu X, Chen H, Hou Y, Ma X, Ye M, Huang R, et al. Adaptive EGF expression sensitizes pancreatic cancer cells to ionizing radiation through activation of the cyclin D1/P53/PARP pathway. Int J Oncol. 2019;54:1466-1480 pubmed publisher
  14. Haikala H, Anttila J, Marques E, Raatikainen T, Ilander M, Hakanen H, et al. Pharmacological reactivation of MYC-dependent apoptosis induces susceptibility to anti-PD-1 immunotherapy. Nat Commun. 2019;10:620 pubmed publisher
  15. LeBlanc L, Lee B, Yu A, Kim M, Kambhampati A, Dupont S, et al. Yap1 safeguards mouse embryonic stem cells from excessive apoptosis during differentiation. elife. 2018;7: pubmed publisher
  16. Yang M, Li C, Zhu S, Cao L, Kroemer G, Zeh H, et al. TFAM is a novel mediator of immunogenic cancer cell death. Oncoimmunology. 2018;7:e1431086 pubmed publisher
  17. Bogenberger J, Whatcott C, Hansen N, Delman D, Shi C, Kim W, et al. Combined venetoclax and alvocidib in acute myeloid leukemia. Oncotarget. 2017;8:107206-107222 pubmed publisher
  18. Mai W, Gosa L, Daniëls V, Ta L, Tsang J, Higgins B, et al. Cytoplasmic p53 couples oncogene-driven glucose metabolism to apoptosis and is a therapeutic target in glioblastoma. Nat Med. 2017;23:1342-1351 pubmed publisher
  19. Yue X, Zuo Y, Ke H, Luo J, Lou L, Qin W, et al. Identification of 4-arylidene curcumin analogues as novel proteasome inhibitors for potential anticancer agents targeting 19S regulatory particle associated deubiquitinase. Biochem Pharmacol. 2017;137:29-50 pubmed publisher
  20. Lee T, Pelletier J. Dependence of p53-deficient cells on the DHX9 DExH-box helicase. Oncotarget. 2017;8:30908-30921 pubmed publisher
  21. Sahu U, Choudhury A, Parvez S, Biswas S, Kar S. Induction of intestinal stemness and tumorigenicity by aberrant internalization of commensal non-pathogenic E. coli. Cell Death Dis. 2017;8:e2667 pubmed publisher
  22. Yuan H, Tan B, Gao S. Tenovin-6 impairs autophagy by inhibiting autophagic flux. Cell Death Dis. 2017;8:e2608 pubmed publisher
  23. Reuther C, Heinzle V, Nölting S, Herterich S, Hahner S, Halilovic E, et al. The HDM2 (MDM2) Inhibitor NVP-CGM097 Inhibits Tumor Cell Proliferation and Shows Additive Effects with 5-Fluorouracil on the p53-p21-Rb-E2F1 Cascade in the p53wild type Neuroendocrine Tumor Cell Line GOT1. Neuroendocrinology. 2018;106:1-19 pubmed publisher
  24. Kayama K, Watanabe S, Takafuji T, Tsuji T, Hironaka K, Matsumoto M, et al. GRWD1 negatively regulates p53 via the RPL11-MDM2 pathway and promotes tumorigenesis. EMBO Rep. 2017;18:123-137 pubmed publisher
  25. Horn T, Ferretti S, Ebel N, Tam A, Ho S, Harbinski F, et al. High-Order Drug Combinations Are Required to Effectively Kill Colorectal Cancer Cells. Cancer Res. 2016;76:6950-6963 pubmed
  26. Pomares H, Palmeri C, Iglesias Serret D, Moncunill Massaguer C, Saura Esteller J, Núñez Vázquez S, et al. Targeting prohibitins induces apoptosis in acute myeloid leukemia cells. Oncotarget. 2016;7:64987-65000 pubmed publisher
  27. Liu H, Li W, Yu X, Gao F, Duan Z, Ma X, et al. EZH2-mediated Puma gene repression regulates non-small cell lung cancer cell proliferation and cisplatin-induced apoptosis. Oncotarget. 2016;7:56338-56354 pubmed publisher
  28. Rada M, Vasileva E, Lezina L, Marouco D, Antonov A, Macip S, et al. Human EHMT2/G9a activates p53 through methylation-independent mechanism. Oncogene. 2017;36:922-932 pubmed publisher
  29. Walerych D, Lisek K, Sommaggio R, Piazza S, Ciani Y, Dalla E, et al. Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. Nat Cell Biol. 2016;18:897-909 pubmed publisher
  30. Tagscherer K, Fassl A, Sinkovic T, Richter J, Schecher S, Macher Goeppinger S, et al. MicroRNA-210 induces apoptosis in colorectal cancer via induction of reactive oxygen. Cancer Cell Int. 2016;16:42 pubmed publisher
  31. O Neill K, Huang K, Zhang J, Chen Y, Luo X. Inactivation of prosurvival Bcl-2 proteins activates Bax/Bak through the outer mitochondrial membrane. Genes Dev. 2016;30:973-88 pubmed publisher
  32. Hornsveld M, Tenhagen M, van de Ven R, Smits A, van Triest M, van Amersfoort M, et al. Restraining FOXO3-dependent transcriptional BMF activation underpins tumour growth and metastasis of E-cadherin-negative breast cancer. Cell Death Differ. 2016;23:1483-92 pubmed publisher
  33. Gilormini M, Malesys C, Armandy E, Manas P, Guy J, Magne N, et al. Preferential targeting of cancer stem cells in the radiosensitizing effect of ABT-737 on HNSCC. Oncotarget. 2016;7:16731-44 pubmed publisher
  34. Yu L, Wu W, Gu C, Zhong D, Zhao X, Kong Y, et al. Obatoclax impairs lysosomal function to block autophagy in cisplatin-sensitive and -resistant esophageal cancer cells. Oncotarget. 2016;7:14693-707 pubmed publisher
  35. Liu X, Tan Y, Zhang C, Zhang Y, Zhang L, Ren P, et al. NAT10 regulates p53 activation through acetylating p53 at K120 and ubiquitinating Mdm2. EMBO Rep. 2016;17:349-66 pubmed publisher
  36. Le Pen J, Maillet L, Sarosiek K, Vuillier C, Gautier F, Montessuit S, et al. Constitutive p53 heightens mitochondrial apoptotic priming and favors cell death induction by BH3 mimetic inhibitors of BCL-xL. Cell Death Dis. 2016;7:e2083 pubmed publisher
  37. De Toni E, Ziesch A, Rizzani A, Török H, Hocke S, Lü S, et al. Inactivation of BRCA2 in human cancer cells identifies a subset of tumors with enhanced sensitivity towards death receptor-mediated apoptosis. Oncotarget. 2016;7:9477-90 pubmed publisher
  38. Thornton T, Delgado P, Chen L, Salas B, Krementsov D, Fernández M, et al. Inactivation of nuclear GSK3β by Ser(389) phosphorylation promotes lymphocyte fitness during DNA double-strand break response. Nat Commun. 2016;7:10553 pubmed publisher
  39. Wang W, Liu H, Dai X, Fang S, Wang X, Zhang Y, et al. p53/PUMA expression in human pulmonary fibroblasts mediates cell activation and migration in silicosis. Sci Rep. 2015;5:16900 pubmed publisher
  40. Amigo Jiménez I, Bailón E, Aguilera Montilla N, Terol M, García Marco J, García Pardo A. Bone marrow stroma-induced resistance of chronic lymphocytic leukemia cells to arsenic trioxide involves Mcl-1 upregulation and is overcome by inhibiting the PI3Kδ or PKCβ signaling pathways. Oncotarget. 2015;6:44832-48 pubmed publisher
  41. Sabirzhanov B, Stoica B, Zhao Z, Loane D, Wu J, Dorsey S, et al. miR-711 upregulation induces neuronal cell death after traumatic brain injury. Cell Death Differ. 2016;23:654-68 pubmed publisher
  42. Wu C, Huang K, Yang T, Li Y, Wen C, Hsu S, et al. The Topoisomerase 1 Inhibitor Austrobailignan-1 Isolated from Koelreuteria henryi Induces a G2/M-Phase Arrest and Cell Death Independently of p53 in Non-Small Cell Lung Cancer Cells. PLoS ONE. 2015;10:e0132052 pubmed publisher
  43. Knorr K, Schneider P, Meng X, Dai H, Smith B, Hess A, et al. MLN4924 induces Noxa upregulation in acute myelogenous leukemia and synergizes with Bcl-2 inhibitors. Cell Death Differ. 2015;22:2133-42 pubmed publisher
  44. Yang N, Gilman P, Mirzayans R, Sun X, Touret N, Weinfeld M, et al. Characterization of the apoptotic response induced by the cyanine dye D112: a potentially selective anti-cancer compound. PLoS ONE. 2015;10:e0125381 pubmed publisher
  45. El Khattouti A, Sheehan N, Monico J, Drummond H, Haikel Y, Brodell R, et al. CD133⁺ melanoma subpopulation acquired resistance to caffeic acid phenethyl ester-induced apoptosis is attributed to the elevated expression of ABCB5: significance for melanoma treatment. Cancer Lett. 2015;357:83-104 pubmed publisher
  46. Eroglu B, Kimbler D, Pang J, Choi J, Moskophidis D, Yanasak N, et al. Therapeutic inducers of the HSP70/HSP110 protect mice against traumatic brain injury. J Neurochem. 2014;130:626-41 pubmed publisher
  47. Bai L, Chen J, McEachern D, Liu L, Zhou H, Aguilar A, et al. BM-1197: a novel and specific Bcl-2/Bcl-xL inhibitor inducing complete and long-lasting tumor regression in vivo. PLoS ONE. 2014;9:e99404 pubmed publisher